This medical study is for people with mixed dyslipidemia. Dyslipidemia means having abnormal amounts of fats like cholesterol or triglycerides in your blood. The study aims to assess the safety and effectiveness of a drug called BW-00112. This is a Phase 2 study, which means it's early in testing but already tested for safety in some people. Participants will be randomly assigned to receive either the drug or a placebo, which is a fake treatment with no actual effect, to compare results.

To take part, you should be between 18 and 75 years old, have certain cholesterol levels, and be on a stable statin medication (a drug that lowers cholesterol) for at least a month. Women must not be pregnant or breastfeeding. If you have certain health problems like recent pancreatitis or uncontrolled diabetes, you cannot join. The study involves taking the medication by a shot under the skin.

• The study requires staying on the same statin medication for its duration.
• Participants must follow the study requirements and attend regular visits.
• Those with significant heart or diabetes issues may not qualify.